Global PRRS Vaccines Market Growth 2021-2026

  • receipt Report ID : 250018
  • calendar_today Published On: Apr, 2021
  • file_copy Pages: 160
  • list Machinery & Equipment

According to this latest study, the 2020 growth of PRRS Vaccines will have significant change from previous year. By the most conservative estimates of global PRRS Vaccines market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the PRRS Vaccines market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of PRRS Vaccines market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.

Live Vaccines

Killed Vaccines

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.

Government Tender

Market Sales

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.

CAHIC

Merial

MSD Animal Health

Chopper Biology

Ceva

ChengDu Tecbond

Veterinary

Ringpu Biology

Qilu Animal

DHN

CAVAC

Komipharm

Agrovet

Bioveta

Jinyu Bio-Technology

Institutul Pasteur

MVP

Tecon

Zoetis

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global PRRS Vaccines Consumption 2016-2026

2.1.2 PRRS Vaccines Consumption CAGR by Region

2.2 PRRS Vaccines Segment by Type

2.2.1 Live Vaccines

2.2.2 Killed Vaccines

2.3 PRRS Vaccines Sales by Type

2.3.1 Global PRRS Vaccines Sales Market Share by Type (2016-2021)

2.3.2 Global PRRS Vaccines Revenue and Market Share by Type (2016-2021)

2.3.3 Global PRRS Vaccines Sale Price by Type (2016-2021)

2.4 PRRS Vaccines Segment by Application

2.4.1 Government Tender

2.4.2 Market Sales

2.5 PRRS Vaccines Sales by Application

2.5.1 Global PRRS Vaccines Sale Market Share by Application (2016-2021)

2.5.2 Global PRRS Vaccines Revenue and Market Share by Application (2016-2021)

2.5.3 Global PRRS Vaccines Sale Price by Application (2016-2021)

3 Global PRRS Vaccines by Company

3.1 Global PRRS Vaccines Sales Market Share by Company

3.1.1 Global PRRS Vaccines Sales by Company (2019-2021)

3.1.2 Global PRRS Vaccines Sales Market Share by Company (2019-2021)

3.2 Global PRRS Vaccines Revenue Market Share by Company

3.2.1 Global PRRS Vaccines Revenue by Company (2019-2021)

3.2.2 Global PRRS Vaccines Revenue Market Share by Company (2019-2021)

3.3 Global PRRS Vaccines Sale Price by Company

3.4 Global Manufacturers PRRS Vaccines Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers PRRS Vaccines Product Location Distribution

3.4.2 Players PRRS Vaccines Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 PRRS Vaccines by Region

4.1 Global PRRS Vaccines by Region

4.1.1 Global PRRS Vaccines Sales by Region

4.1.2 Global PRRS Vaccines Revenue by Region

4.2 Americas PRRS Vaccines Sales Growth

4.3 APAC PRRS Vaccines Sales Growth

4.4 Europe PRRS Vaccines Sales Growth

4.5 Middle East & Africa PRRS Vaccines Sales Growth

5 Americas

5.1 Americas PRRS Vaccines Sales by Country

5.1.1 Americas PRRS Vaccines Sales by Country (2016-2021)

5.1.2 Americas PRRS Vaccines Revenue by Country (2016-2021)

5.2 Americas PRRS Vaccines Sales by Type

5.3 Americas PRRS Vaccines Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC PRRS Vaccines Sales by Region

6.1.1 APAC PRRS Vaccines Sales by Region (2016-2021)

6.1.2 APAC PRRS Vaccines Revenue by Region (2016-2021)

6.2 APAC PRRS Vaccines Sales by Type

6.3 APAC PRRS Vaccines Sales by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe PRRS Vaccines by Country

7.1.1 Europe PRRS Vaccines Sales by Country (2016-2021)

7.1.2 Europe PRRS Vaccines Revenue by Country (2016-2021)

7.2 Europe PRRS Vaccines Sales by Type

7.3 Europe PRRS Vaccines Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa PRRS Vaccines by Country

8.1.1 Middle East & Africa PRRS Vaccines Sales by Country (2016-2021)

8.1.2 Middle East & Africa PRRS Vaccines Revenue by Country (2016-2021)

8.2 Middle East & Africa PRRS Vaccines Sales by Type

8.3 Middle East & Africa PRRS Vaccines Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Country

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 PRRS Vaccines Distributors

10.3 PRRS Vaccines Customer

11 Global PRRS Vaccines Market Forecast

11.1 Global PRRS Vaccines Forecast by Region

11.1.1 Global PRRS Vaccines Forecast by Regions (2021-2026)

11.2.2 Global PRRS Vaccines Revenue Forecast by Regions (2021-2026)

11.2 Americas Forecast by Countries

11.3 APAC Forecast by Region

11.4 Europe Forecast by Countries

11.5 Middle East & Africa Forecast by Countries

11.6 Global PRRS Vaccines Forecast by Type

11.7 Global PRRS Vaccines Forecast by Application

12 Key Players Analysis

12.1 CAHIC

12.1.1 CAHIC CAHIC Company Information

12.1.2 CAHIC PRRS Vaccines Product Offered

12.1.3 CAHIC PRRS Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)

12.1.4 CAHIC Main Business Overview

12.1.5 CAHIC Latest Developments

12.2 Merial

12.2.1 Merial Company Information

12.2.2 Merial PRRS Vaccines Product Offered

12.2.3 Merial PRRS Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)

12.2.4 Merial Main Business Overview

12.2.5 Merial Latest Developments

12.3 MSD Animal Health

12.3.1 MSD Animal Health Company Information

12.3.2 MSD Animal Health PRRS Vaccines Product Offered

12.3.3 MSD Animal Health PRRS Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)

12.3.4 MSD Animal Health Main Business Overview

12.3.5 MSD Animal Health Latest Developments

12.4 Chopper Biology

12.4.1 Chopper Biology Company Information

12.4.2 Chopper Biology PRRS Vaccines Product Offered

12.4.3 Chopper Biology PRRS Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)

12.4.4 Chopper Biology Main Business Overview

12.4.5 Chopper Biology Latest Developments

12.5 Ceva

12.5.1 Ceva Company Information

12.5.2 Ceva PRRS Vaccines Product Offered

12.5.3 Ceva PRRS Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)

12.5.4 Ceva Main Business Overview

12.5.5 Ceva Latest Developments

12.6 ChengDu Tecbond

12.6.1 ChengDu Tecbond Company Information

12.6.2 ChengDu Tecbond PRRS Vaccines Product Offered

12.6.3 ChengDu Tecbond PRRS Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)

12.6.4 ChengDu Tecbond Main Business Overview

12.6.5 ChengDu Tecbond Latest Developments

12.7 Veterinary

12.7.1 Veterinary Company Information

12.7.2 Veterinary PRRS Vaccines Product Offered

12.7.3 Veterinary PRRS Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)

12.7.4 Veterinary Main Business Overview

12.7.5 Veterinary Latest Developments

12.8 Ringpu Biology

12.8.1 Ringpu Biology Company Information

12.8.2 Ringpu Biology PRRS Vaccines Product Offered

12.8.3 Ringpu Biology PRRS Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)

12.8.4 Ringpu Biology Main Business Overview

12.8.5 Ringpu Biology Latest Developments

12.9 Qilu Animal

12.9.1 Qilu Animal Company Information

12.9.2 Qilu Animal PRRS Vaccines Product Offered

12.9.3 Qilu Animal PRRS Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)

12.9.4 Qilu Animal Main Business Overview

12.9.5 Qilu Animal Latest Developments

12.10 DHN

12.10.1 DHN Company Information

12.10.2 DHN PRRS Vaccines Product Offered

12.10.3 DHN PRRS Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)

12.10.4 DHN Main Business Overview

12.10.5 DHN Latest Developments

12.11 CAVAC

12.11.1 CAVAC Company Information

12.11.2 CAVAC PRRS Vaccines Product Offered

12.11.3 CAVAC PRRS Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)

12.11.4 CAVAC Main Business Overview

12.11.5 CAVAC Latest Developments

12.12 Komipharm

12.12.1 Komipharm Company Information

12.12.2 Komipharm PRRS Vaccines Product Offered

12.12.3 Komipharm PRRS Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)

12.12.4 Komipharm Main Business Overview

12.12.5 Komipharm Latest Developments

12.13 Agrovet

12.13.1 Agrovet Company Information

12.13.2 Agrovet PRRS Vaccines Product Offered

12.13.3 Agrovet PRRS Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)

12.13.4 Agrovet Main Business Overview

12.13.5 Agrovet Latest Developments

12.14 Bioveta

12.14.1 Bioveta Company Information

12.14.2 Bioveta PRRS Vaccines Product Offered

12.14.3 Bioveta PRRS Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)

12.14.4 Bioveta Main Business Overview

12.14.5 Bioveta Latest Developments

12.15 Jinyu Bio-Technology

12.15.1 Jinyu Bio-Technology Company Information

12.15.2 Jinyu Bio-Technology PRRS Vaccines Product Offered

12.15.3 Jinyu Bio-Technology PRRS Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)

12.15.4 Jinyu Bio-Technology Main Business Overview

12.15.5 Jinyu Bio-Technology Latest Developments

12.16 Institutul Pasteur

12.16.1 Institutul Pasteur Company Information

12.16.2 Institutul Pasteur PRRS Vaccines Product Offered

12.16.3 Institutul Pasteur PRRS Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)

12.16.4 Institutul Pasteur Main Business Overview

12.16.5 Institutul Pasteur Latest Developments

12.17 MVP

12.17.1 MVP Company Information

12.17.2 MVP PRRS Vaccines Product Offered

12.17.3 MVP PRRS Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)

12.17.4 MVP Main Business Overview

12.17.5 MVP Latest Developments

12.18 Tecon

12.18.1 Tecon Company Information

12.18.2 Tecon PRRS Vaccines Product Offered

12.18.3 Tecon PRRS Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)

12.18.4 Tecon Main Business Overview

12.18.5 Tecon Latest Developments

12.19 Zoetis

12.19.1 Zoetis Company Information

12.19.2 Zoetis PRRS Vaccines Product Offered

12.19.3 Zoetis PRRS Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)

12.19.4 Zoetis Main Business Overview

12.19.5 Zoetis Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. PRRS Vaccines Consumption CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of Live Vaccines

Table 3. Major Players of Killed Vaccines

Table 4. Global PRRS Vaccines Sales by Type (2016-2021) & (K Units)

Table 5. Global PRRS Vaccines Sales Market Share by Type (2016-2021)

Table 6. Global PRRS Vaccines Revenue by Type (2016-2021) & ($ million)

Table 7. Global PRRS Vaccines Revenue Market Share by Type (2016-2021)

Table 8. Global PRRS Vaccines Sale Price by Type (2016-2021)

Table 9. Global PRRS Vaccines Sales by Application (2016-2021) & (K Units)

Table 10. Global PRRS Vaccines Sales Market Share by Application (2016-2021)

Table 11. Global PRRS Vaccines Value by Application (2016-2021)

Table 12. Global PRRS Vaccines Revenue Market Share by Application (2016-2021)

Table 13. Global PRRS Vaccines Sale Price by Application (2016-2021)

Table 14. Global PRRS Vaccines Sales by Company (2019-2021) & (K Units)

Table 15. Global PRRS Vaccines Sales Market Share by Company (2019-2021)

Table 16. Global PRRS Vaccines Revenue by Company (2019-2021) ($ Millions)

Table 17. Global PRRS Vaccines Revenue Market Share by Company (2019-2021)

Table 18. Global PRRS Vaccines Sale Price by Company (2019-2021)

Table 19. Key Manufacturers PRRS Vaccines Producing Area Distribution and Sales Area

Table 20. Players PRRS Vaccines Products Offered

Table 21. PRRS Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

Table 22. New Products and Potential Entrants

Table 23. Mergers & Acquisitions, Expansion

Table 24. Global PRRS Vaccines Sales by Region (2016-2021) (K Units)

Table 25. Global PRRS Vaccines Sales Market Share by Region (2016-2021)

Table 26. Global PRRS Vaccines Revenue by Region (2016-2021) & ($ Millions)

Table 27. Global PRRS Vaccines Revenue Market Share by Region (2016-2021)

Table 28. Americas PRRS Vaccines Sales by Country (2016-2021) & (K Units)

Table 29. Americas PRRS Vaccines Sales Market Share by Country (2016-2021)

Table 30. Americas PRRS Vaccines Revenue by Country (2016-2021) & ($ Millions)

Table 31. Americas PRRS Vaccines Revenue Market Share by Country (2016-2021)

Table 32. Americas PRRS Vaccines Sales by Type (2016-2021) & (K Units)

Table 33. Americas PRRS Vaccines Sales Market Share by Type (2016-2021)

Table 34. Americas PRRS Vaccines Sales by Application (2016-2021) & (K Units)

Table 35. Americas PRRS Vaccines Sales Market Share by Application (2016-2021)

Table 36. APAC PRRS Vaccines Sales by Region (2016-2021) & (K Units)

Table 37. APAC PRRS Vaccines Sales Market Share by Region (2016-2021)

Table 38. APAC PRRS Vaccines Revenue by Region (2016-2021) & ($ Millions)

Table 39. APAC PRRS Vaccines Revenue Market Share by Region (2016-2021)

Table 40. APAC PRRS Vaccines Sales by Type (2016-2021) & (K Units)

Table 41. APAC PRRS Vaccines Sales Market Share by Type (2016-2021)

Table 42. APAC PRRS Vaccines Sales by Application (2016-2021) & (K Units)

Table 43. APAC PRRS Vaccines Sales Market Share by Application (2016-2021)

Table 44. Europe PRRS Vaccines Sales by Country (2016-2021) & (K Units)

Table 45. Europe PRRS Vaccines Sales Market Share by Country (2016-2021)

Table 46. Europe PRRS Vaccines Revenue by Country (2016-2021) & ($ Millions)

Table 47. Europe PRRS Vaccines Revenue Market Share by Country (2016-2021)

Table 48. Europe PRRS Vaccines Sales by Type (2016-2021) & (K Units)

Table 49. Europe PRRS Vaccines Sales Market Share by Type (2016-2021)

Table 50. Europe PRRS Vaccines Sales by Application (2016-2021) & (K Units)

Table 51. Europe PRRS Vaccines Sales Market Share by Application (2016-2021)

Table 52. Middle East & Africa PRRS Vaccines Sales by Country (2016-2021) & (K Units)

Table 53. Middle East & Africa PRRS Vaccines Sales Market Share by Country (2016-2021)

Table 54. Middle East & Africa PRRS Vaccines Revenue by Country (2016-2021) & ($ Millions)

Table 55. Middle East & Africa PRRS Vaccines Revenue Market Share by Country (2016-2021)

Table 56. Middle East & Africa PRRS Vaccines Sales by Type (2016-2021) & (K Units)

Table 57. Middle East & Africa PRRS Vaccines Sales Market Share by Type (2016-2021)

Table 58. Middle East & Africa PRRS Vaccines Sales by Application (2016-2021) & (K Units)

Table 59. Middle East & Africa PRRS Vaccines Sales Market Share by Application (2016-2021)

Table 60. Global PRRS Vaccines Sales Forecast by Type (2021-2026) & (K Units)

Table 61. Global PRRS Vaccines Sales Market Share Forecast by Type (2021-2026)

Table 62. Global PRRS Vaccines Revenue Forecast by Type (2021-2026) & ($ Millions)

Table 63. Global PRRS Vaccines Revenue Market Share Forecast by Type (2021-2026)

Table 64. Global PRRS Vaccines Sales Forecast by Application (2021-2026) & (K Units)

Table 65. Global PRRS Vaccines Sales Market Share Forecast by Application (2021-2026)

Table 66. Global PRRS Vaccines Revenue Forecast by Application (2021-2026) & ($ Millions)

Table 67. Global PRRS Vaccines Revenue Market Share Forecast by Application (2021-2026)

Table 68. CAHIC Basic Information, PRRS Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 69. CAHIC PRRS Vaccines Product Offered

Table 70. CAHIC PRRS Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 71. CAHIC Main Business

Table 72. CAHIC Latest Developments

Table 73. Merial Basic Information, PRRS Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 74. Merial PRRS Vaccines Product Offered

Table 75. Merial PRRS Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 76. Merial Main Business

Table 77. Merial Latest Developments

Table 78. MSD Animal Health Basic Information, PRRS Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 79. MSD Animal Health PRRS Vaccines Product Offered

Table 80. MSD Animal Health PRRS Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 81. MSD Animal Health Main Business

Table 82. MSD Animal Health Latest Developments

Table 83. Chopper Biology Basic Information, PRRS Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 84. Chopper Biology PRRS Vaccines Product Offered

Table 85. Chopper Biology PRRS Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 86. Chopper Biology Main Business

Table 87. Chopper Biology Latest Developments

Table 88. Ceva Basic Information, PRRS Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 89. Ceva PRRS Vaccines Product Offered

Table 90. Ceva PRRS Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 91. Ceva Main Business

Table 92. Ceva Latest Developments

Table 93. ChengDu Tecbond Basic Information, PRRS Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 94. ChengDu Tecbond PRRS Vaccines Product Offered

Table 95. ChengDu Tecbond PRRS Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 96. ChengDu Tecbond Main Business

Table 97. ChengDu Tecbond Latest Developments

Table 98. Veterinary Basic Information, PRRS Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 99. Veterinary PRRS Vaccines Product Offered

Table 100. Veterinary PRRS Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 101. Veterinary Main Business

Table 102. Veterinary Latest Developments

Table 103. Ringpu Biology Basic Information, PRRS Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 104. Ringpu Biology PRRS Vaccines Product Offered

Table 105. Ringpu Biology PRRS Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 106. Ringpu Biology Main Business

Table 107. Ringpu Biology Latest Developments

Table 108. Qilu Animal Basic Information, PRRS Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 109. Qilu Animal PRRS Vaccines Product Offered

Table 110. Qilu Animal PRRS Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 111. Qilu Animal Main Business

Table 112. Qilu Animal Latest Developments

Table 113. DHN Basic Information, PRRS Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 114. DHN PRRS Vaccines Product Offered

Table 115. DHN PRRS Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 116. DHN Main Business

Table 117. DHN Latest Developments

Table 118. CAVAC Basic Information, PRRS Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 119. CAVAC PRRS Vaccines Product Offered

Table 120. CAVAC PRRS Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 121. CAVAC Main Business

Table 122. CAVAC Latest Developments

Table 123. Komipharm Basic Information, PRRS Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 124. Komipharm PRRS Vaccines Product Offered

Table 125. Komipharm PRRS Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 126. Komipharm Main Business

Table 127. Komipharm Latest Developments

Table 128. Agrovet Basic Information, PRRS Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 129. Agrovet PRRS Vaccines Product Offered

Table 130. Agrovet PRRS Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 131. Agrovet Main Business

Table 132. Agrovet Latest Developments

Table 133. Bioveta Basic Information, PRRS Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 134. Bioveta PRRS Vaccines Product Offered

Table 135. Bioveta PRRS Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 136. Bioveta Main Business

Table 137. Bioveta Latest Developments

Table 138. Jinyu Bio-Technology Basic Information, PRRS Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 139. Jinyu Bio-Technology PRRS Vaccines Product Offered

Table 140. Jinyu Bio-Technology PRRS Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 141. Jinyu Bio-Technology Main Business

Table 142. Jinyu Bio-Technology Latest Developments

Table 143. Institutul Pasteur Basic Information, PRRS Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 144. Institutul Pasteur PRRS Vaccines Product Offered

Table 145. Institutul Pasteur PRRS Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 146. Institutul Pasteur Main Business

Table 147. Institutul Pasteur Latest Developments

Table 148. MVP Basic Information, PRRS Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 149. MVP PRRS Vaccines Product Offered

Table 150. MVP PRRS Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 151. MVP Main Business

Table 152. MVP Latest Developments

Table 153. Tecon Basic Information, PRRS Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 154. Tecon PRRS Vaccines Product Offered

Table 155. Tecon PRRS Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 156. Tecon Main Business

Table 157. Tecon Latest Developments

Table 158. Zoetis Basic Information, PRRS Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 159. Zoetis PRRS Vaccines Product Offered

Table 160. Zoetis PRRS Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 161. Zoetis Main Business

Table 162. Zoetis Latest Developments

List of Figures

Figure 1. Picture of PRRS Vaccines

Figure 2. PRRS Vaccines Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global PRRS Vaccines Sales Growth Rate 2016-2026 (K Units)

Figure 7. Global PRRS Vaccines Revenue Growth Rate 2016-2026 ($ Millions)

Figure 8. PRRS Vaccines Sales by Region (2021 & 2026) & ($ millions)

Figure 9. Product Picture of Live Vaccines

Figure 10. Product Picture of Killed Vaccines

Figure 11. Global PRRS Vaccines Sales Market Share by Type in 2020

Figure 12. Global PRRS Vaccines Revenue Market Share by Type (2016-2021)

Figure 13. PRRS Vaccines Consumed in Government Tender

Figure 14. Global PRRS Vaccines Market: Government Tender (2016-2021) & (K Units)

Figure 15. PRRS Vaccines Consumed in Market Sales

Figure 16. Global PRRS Vaccines Market: Market Sales (2016-2021) & (K Units)

Figure 17. Global PRRS Vaccines Sales Market Share by Application (2016-2021)

Figure 18. Global PRRS Vaccines Revenue Market Share by Application in 2020

Figure 19. Global PRRS Vaccines Revenue Market by Company in 2020 ($ Million)

Figure 20. Global PRRS Vaccines Revenue Market Share by Company in 2020

Figure 21. Global PRRS Vaccines Sales Market Share by Regions (2016-2021)

Figure 22. Global PRRS Vaccines Revenue Market Share by Region in 2020

Figure 23. Americas PRRS Vaccines Sales 2016-2021 (K Units)

Figure 24. Americas PRRS Vaccines Revenue 2016-2021 ($ Millions)

Figure 25. APAC PRRS Vaccines Sales 2016-2021 (K Units)

Figure 26. APAC PRRS Vaccines Revenue 2016-2021 ($ Millions)

Figure 27. Europe PRRS Vaccines Sales 2016-2021 (K Units)

Figure 28. Europe PRRS Vaccines Revenue 2016-2021 ($ Millions)

Figure 29. Middle East & Africa PRRS Vaccines Sales 2016-2021 (K Units)

Figure 30. Middle East & Africa PRRS Vaccines Revenue 2016-2021 ($ Millions)

Figure 31. Americas PRRS Vaccines Sales Market Share by Country in 2020

Figure 32. Americas PRRS Vaccines Revenue Market Share by Country in 2020

Figure 33. Americas PRRS Vaccines Sales Market Share by Type in 2020

Figure 34. Americas PRRS Vaccines Sales Market Share by Application in 2020

Figure 35. United States PRRS Vaccines Revenue Growth 2016-2021 ($ Millions)

Figure 36. Canada PRRS Vaccines Revenue Growth 2016-2021 ($ Millions)

Figure 37. Mexico PRRS Vaccines Revenue Growth 2016-2021 ($ Millions)

Figure 38. Brazil PRRS Vaccines Revenue Growth 2016-2021 ($ Millions)

Figure 39. APAC PRRS Vaccines Sales Market Share by Region in 2020

Figure 40. APAC PRRS Vaccines Revenue Market Share by Regions in 2020

Figure 41. APAC PRRS Vaccines Sales Market Share by Type in 2020

Figure 42. APAC PRRS Vaccines Sales Market Share by Application in 2020

Figure 43. China PRRS Vaccines Revenue Growth 2016-2021 ($ Millions)

Figure 44. Japan PRRS Vaccines Revenue Growth 2016-2021 ($ Millions)

Figure 45. Korea PRRS Vaccines Revenue Growth 2016-2021 ($ Millions)

Figure 46. Southeast Asia PRRS Vaccines Revenue Growth 2016-2021 ($ Millions)

Figure 47. India PRRS Vaccines Revenue Growth 2016-2021 ($ Millions)

Figure 48. Australia PRRS Vaccines Revenue Growth 2016-2021 ($ Millions)

Figure 49. Europe PRRS Vaccines Sales Market Share by Country in 2020

Figure 50. Europe PRRS Vaccines Revenue Market Share by Country in 2020

Figure 51. Europe PRRS Vaccines Sales Market Share by Type in 2020

Figure 52. Europe PRRS Vaccines Sales Market Share by Application in 2020

Figure 53. Germany PRRS Vaccines Revenue Growth 2016-2021 ($ Millions)

Figure 54. France PRRS Vaccines Revenue Growth 2016-2021 ($ Millions)

Figure 55. UK PRRS Vaccines Revenue Growth 2016-2021 ($ Millions)

Figure 56. Italy PRRS Vaccines Revenue Growth 2016-2021 ($ Millions)

Figure 57. Russia PRRS Vaccines Revenue Growth 2016-2021 ($ Millions)

Figure 58. Middle East & Africa PRRS Vaccines Sales Market Share by Country in 2020

Figure 59. Middle East & Africa PRRS Vaccines Revenue Market Share by Country in 2020

Figure 60. Middle East & Africa PRRS Vaccines Sales Market Share by Type in 2020

Figure 61. Middle East & Africa PRRS Vaccines Sales Market Share by Application in 2020

Figure 62. Egypt PRRS Vaccines Revenue Growth 2016-2021 ($ Millions)

Figure 63. South Africa PRRS Vaccines Revenue Growth 2016-2021 ($ Millions)

Figure 64. Israel PRRS Vaccines Revenue Growth 2016-2021 ($ Millions)

Figure 65. Turkey PRRS Vaccines Revenue Growth 2016-2021 ($ Millions)

Figure 66. GCC Country PRRS Vaccines Revenue Growth 2016-2021 ($ Millions)

Figure 67. Channels of Distribution

Figure 68. Distributors Profiles

Please fill the form below, to recieve the report sample


+1